Dexamethasone augmentation in treatment-resistant depression

Acta Psychiatrica Scandinavica

Volumn 95, Issue 1, 1997, Pages 58-61

  Dinan, T G ^a   Lavelle, E ^a   Cooney, J ^a   Burnett, F ^a   Scott, L ^a   Dash, A ^a   Thakore, J ^a   Berti, C ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

depression; dexamethasone; fluoxetine; sertraline; treatment resistance

Indexed keywords

DEXAMETHASONE; FLUOXETINE; HYDROCORTISONE; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG COMBINATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0031043561     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb00374.x     Document Type: Article

References (24)

1. ROTHSCHILD AJ, SAMSON JA, BOND TC, LUCIANA MM, SCHILDKRAUT JJ, SCHATZBERG AF. Hypothalamic-pituitary-adrenal axis activity and one-year outcome in depression. Biol Psychiatry 1993: 34: 392-400.
2. AMSTERDAM JD, MARINELLI DL, ARGER P, WINOKUR A. Assessment of adrenal gland volume by computer tomography in depressed patients and healthy volunteers: a pilot study. Psychiatr Res 1987: 21: 189-197.
3. UR E, DINAN TG, O'KEANE V et al. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status. Neuroendocrinology 1992: 56: 533-553.
4. CARROLL BJ. Dexamethasone suppression test for melancholia. Br J Psychiatry 1982: 140: 292-304.
5. YOUNG EA, HASKETT RF, MURPHY-WEINBERG V. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 1991: 48: 693-699.
6. BARDEN N, REUL JMHM, HOLSBOER F. Do antidepressants stablise mood through actions on the hypothalamic-pituitary-adrenocortical system? TINS 1995: 18: 6-11.
7. SPITZ IM, BARDIN CW. Mifepristone (RU486) - a modulator of progestin and glucocorticoid action. N Engl J Med 1993: 329: 404-412.
8. MURPHY BEB. Treatment of major depression with steroid suppressive drugs. J Steroid Biochem Mol Biol 1991: 39: 239-244.
9. O'DWYER AM, LIGHTMAN SL, MARKS MN, CHECKLEY S. Treatment of major depression with metyrapone and hydrocortisone. J Affect Dis 1995: 33: 123-128.
10. THAKORE JH, DINAN TG. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 1995: 37: 364-368.
11. PEPIM MC, BEAULIEU S, BARDEN N. Antidepressant-regulated glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol Brain Res 1989: 6: 77-83.
12. REUL JMHM, STEC I, SODER M, HOLSBOER F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 1993: 135: 312-320.
13. DINAN TG. A rational approach to the non-responding depressed patient. Int Clin Psychopharmacology 1993: 8: 221-223.
14. DEMONTIGNY C, GRUNBERG GF, MAYER A, DESCHENES JP. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981: 138: 252-256.
15. DINAN TG, BARRY S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination in depressed tricyclic non-responders. Acta Psychiatr Scand 1989: 80: 97-100.
16. JOFFE RT, SINGER W, LEVITT AJ, MACDONALD C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993: 50: 387-393.
17. PAYKEL ES, HALE AS. Recent advances in the treatment of depression. In: DEAKIN JFW, ed. The biology of depression. London: Gaskell, 1986: 153-173.
18. ARTIGAS F, PEREZ V, ALVAREZ E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994: 51: 248-251.
19. ARANA GW, SANTOS AB, LARAIA MT et al. Dexamethasone for the treatment of depression: a randomised, placebo-controlled, double-blind trial. Am J Psychiatry 1995: 152: 265-267.
20. DASH RJ, ENGLAND BC, REES MIDGELEY A, NISWENDER GD. A specific non-chromatographic radioimmunoassay for human plasma cortisol. Steroids 1975: 26: 647-661.
21. DINAN TG. The role of steroids in the genesis of depression: a psychobiological perspective. Br J Psychiatry 1994: 164: 365-372.
22. LING MH, PERRY PJ, TSUANG MT. Side-effects of corticosteroid therapy. Arch Gen Psychiatry 1981: 38: 471-477.
23. FLESHNER M, WATKINS LR, LOCKWOOD LL et al. Blockade of the hypothalamic-pituitary-adrenal response to stress by intraventricular injection of dexamethasone: a method for studying the stress-induced peripheral effects of glucocorticoids. Psychoneuroendocrinology 1993: 18: 251-263.
24. TRAPP T, HOLSBOER F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol Sci 1996: 17: 145-149.